2seventy bio, Inc. short interest in 2022
In 2022, 2seventy bio, Inc.'s disclosed short interest ran from 8.36% of shares outstanding on 14 Jan 2022 to 6.48% on 30 Dec 2022, a change of -1.88 percentage points. The year's high was 11.00% on 31 Jan 2022 and its low 4.34% on 15 Dec 2022, averaging 6.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.88 days on 30 Sep 2022. Full history: 2seventy bio, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 8.36% (14 Jan 2022)
- End of year
- 6.48% (30 Dec 2022)
- Change
- -1.88 pp
- High
- 11.00% (31 Jan 2022)
- Low
- 4.34% (15 Dec 2022)
- Average
- 6.81%
- Highest days to cover
- 7.88 (30 Sep 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.36% | 4.79 | results (8-K) |
| 31 Jan 2022 | 11.00% | 4.87 | |
| 15 Feb 2022 | 10.32% | 5.60 | |
| 28 Feb 2022 | 8.59% | 5.66 | |
| 15 Mar 2022 | 8.31% | 5.89 | |
| 31 Mar 2022 | 6.66% | 4.15 | results (8-K), 10-K filed, results (8-K) |
| 14 Apr 2022 | 7.00% | 6.78 | |
| 29 Apr 2022 | 7.73% | 7.62 | |
| 13 May 2022 | 7.92% | 5.63 | 10-Q filed, results (8-K) |
| 31 May 2022 | 7.07% | 5.06 | |
| 15 Jun 2022 | 7.25% | 4.37 | |
| 30 Jun 2022 | 6.86% | 2.84 | |
| 15 Jul 2022 | 6.06% | 5.20 | |
| 29 Jul 2022 | 6.48% | 6.89 | |
| 15 Aug 2022 | 6.36% | 4.54 | 10-Q filed |
| 31 Aug 2022 | 5.67% | 6.84 | |
| 15 Sep 2022 | 5.48% | 7.44 | |
| 30 Sep 2022 | 6.27% | 7.88 | |
| 14 Oct 2022 | 4.95% | 5.72 | |
| 31 Oct 2022 | 5.41% | 5.30 | |
| 15 Nov 2022 | 4.58% | 4.25 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 4.39% | 4.45 | |
| 15 Dec 2022 | 4.34% | 3.77 | |
| 30 Dec 2022 | 6.48% | 3.77 |
See also: 2seventy bio, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.